Receptos Inc (RCPT)

[TREND1]

SAN DIEGO, July 14, 2015 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Receptos Inc. (NASDAQ: RCPT) by Celgene Corporation (NASDAQ: CELG). On July 14, 2015, the two companies announced the signing of a definitive merger agreement pursuant to which Celgene will acquire Receptos. Under the terms of the agreement, Receptos shareholders will receive $232.00 in cash for each share of Receptos common stock.